Nebularine (9-2'-deoxy-beta-D-ribofuranosylpurine) has the template characteristics of adenine in vivo and in vitro.
Nebularine (9-beta-D-ribofuranosylpurine; Nb) is a naturally occurring nucleoside with structural features suggestive of a universal base. However, previous observations based on thermal melting characteristics of oligonucleotides suggested that Nb formed stable pairs only with thymine. To determine the template characteristics of Nb, we constructed M13 viral single-stranded DNA (ssDNA) molecules bearing a single site-specific deoxynebularine (9-2'-deoxy-beta-D-ribofuranosylpurine) residue. The ssDNA constructs were transfected into Escherichia coli cells to determine the specificity of base insertion opposite Nb, as well as to determine the effect of Nb on the replicability of the transfected DNA. Base insertion opposite Nb, analyzed by a multiplex sequencing technology, suggests that Nb has the template characteristics of adenine. Analysis of DNA replicability, measured as transfection efficiency, indicates that Nb does not block DNA replication. UV irradiation of host cells before transfection did not significantly affect survival or base insertion specificity within the limits of multiplex sequencing technology employed, suggesting that inducible mutagenic phenomena appear to have only minor effects on translesion synthesis across Nb. In addition, in vitro DNA elongation experiments on oligonucleotide templates using E. coli DNA polymerase I (Klenow fragment) as the model polymerase showed that Nb templates for T, but not for other bases under the tested conditions. The data reported in this communication underscore the importance of base-pair geometry as a specificity-determinant during base insertion by replicative polymerases.
Rahman
M S
MS
Department of Microbiology and Molecular Genetics, UMD-New Jersey Medical School, Newark 07103-2714, USA.
Humayun
M Z
MZ
D000225:Adenine / Q000378:metabolism*; D000970:Antineoplastic Agents / Q000378:metabolism / Q000494:pharmacology; D017104:Bacteriophage M13 / Q000187:drug effects / Q000235:genetics; D001482:Base Composition; D004261:DNA Replication / Q000187:drug effects*; D004251:DNA Transposable Elements; D004277:DNA, Single-Stranded / Q000187:drug effects / Q000235:genetics; D004926:Escherichia coli / Q000187:drug effects / Q000235:genetics; D011684:Purine Nucleosides / Q000378:metabolism* / Q000494:pharmacology*; D012263:Ribonucleosides / Q000378:metabolism* / Q000494:pharmacology*; D013379:Substrate Specificity; D013698:Templates, Genetic
D000970:Antineoplastic Agents; D004251:DNA Transposable Elements; D004277:DNA, Single-Stranded; D011684:Purine Nucleosides; D012263:Ribonucleosides; C005248:nebularine; D000225:Adenine